CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 72 filers reported holding CONATUS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $323,000 | +1694.4% | 55,008 | +1619.0% | 0.02% | +1050.0% |
Q3 2017 | $18,000 | -61.7% | 3,200 | -64.4% | 0.00% | -66.7% |
Q4 2016 | $47,000 | +2250.0% | 9,000 | +800.0% | 0.01% | – |
Q3 2016 | $2,000 | -95.3% | 1,000 | -83.3% | 0.00% | -100.0% |
Q1 2015 | $43,000 | – | 6,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JBF Capital, Inc. | 520,553 | $161,000 | 0.03% |
Kalos Management, Inc. | 43,940 | $13,000 | 0.01% |
ACADIAN ASSET MANAGEMENT LLC | 1,351,000 | $419,000 | 0.00% |
Quilter Plc | 60,546 | $19,000 | 0.00% |
ALBION FINANCIAL GROUP /UT | 12,000 | $4,000 | 0.00% |
REILLY FINANCIAL ADVISORS, LLC | 22,011 | $7,000 | 0.00% |
MORGAN STANLEY | 1,900 | $1,000 | 0.00% |
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 24,900 | $8,000 | 0.00% |
BlackRock Inc. | 645,611 | $200,000 | 0.00% |
Bank of New York Mellon Corp | 137,500 | $43,000 | 0.00% |